neonatal abstinence syndrome

Novel approach to neonatal abstinence syndrome shortens hospital stayInfants with neonatal abstinence syndrome (NAS) treated with supportive nonpharmacologic interventions have a substantially shorter hospital stay and are less likely to be treated with morphine, a new study shows.
A place for acupuncture in NAS treatment?Adjunctive laser acupuncture reduces the need for morphine therapy in neonatal abstinence syndrome (NAS).
More babies born with drug withdrawal symptomsFrom 2009 to 2012, the number of babies born in the United States with neonatal abstinence syndrome—symptoms of opioid withdrawal—almost doubled, pushing associated hospital costs to $1.5 billion, a new study reports.
Study: Babies exposed to narcotic pain relievers more likely to experience drug withdrawal syndromePregnant women are commonly being prescribed opioids — narcotic pain relievers such as hydrocodone — which results in an increased likelihood of neonatal abstinence syndrome (NAS), a drug withdrawal syndrome that opioid-related infants experience shortly after birth, according to a study in Pediatrics.
Neonatal abstinence syndromeNeonatal abstinence syndrome that occurs in a newborn following birth is attributed to the withdrawal of opioids, prescription medications, or illicit drugs that were ingested by the mother during pregnancy. Because symptoms may or may not be present at birth, early screening and pharmacologic treatment can stabilize an infant experiencing narcotic withdrawal.
Study explores genetic factors in neonatal abstinence syndrome